Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC

Abroad (travel likely)RecruitingPHASE2

Conditions

Hepatocellular Carcinoma · Hepatocellular Cancer · Colorectal Cancer · Colorectal Carcinoma · Liver Metastases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Cancer Center Singapore, Singapore, Singapore

Study leads

Si Lin Koo
Principal Investigator
National Cancer Centre, Singapore

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Carcinoma, Hepatocellular · Hepatocellular Cancer · Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Los Angeles, United States

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma · HCC

Abroad (travel likely)RecruitingPHASE2

Orange, United States

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Biliary Tract Cancer · Breast Cancer · Cervical Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Denver, United States · Miami, United States

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Hepatocellular Carcinoma · Hepatocellular Cancer · Hepatocellular Carcinoma Non-resectable

Abroad (travel likely)RecruitingPHASE2

Seoul, South Korea